Navigation Links
Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
Date:11/1/2007

h their proven success in building new markets, Warner Chilcott is a great partner for launching this product."

About the ED Market

According to IMS data, the U.S. ED market in 2006 was about $1.5 billion - - dominated by oral PDE5 treatments. Despite the availability of today's oral and other therapies, there is still a need for new, safe and effective treatments, especially for those patients who cannot or do not respond well to oral medication. Alprostadil, well-recognized as a safe and effective drug for the treatment of ED, is currently marketed as both an injectable and intra- urethral pellet. NexMed's topical product provides a more patient-friendly alternative due to its non-invasive ease of administration.

About Warner Chilcott

Warner Chilcott is a specialty pharmaceutical company focused on developing, manufacturing, marketing and selling branded prescription pharmaceutical products in women's healthcare and dermatology in the United States. (WCRX-G) Read more on http://www.warnerchilcott.com.

About NexMed

NexMed, Inc. is leveraging its proprietary NexACT(R) drug delivery technology to develop innovative topical pharmaceutical products that address unmet medical needs. NexMed's novel, onychomycosis treatment, licensed to Novartis, is currently in pivotal Phase 3 trials in the U.S. and Europe. NexMed's pipeline also includes a Phase 2 treatment for female sexual arousal disorder and an early stage treatment for psoriasis.

Read more on http://www.nexmed.com

Warner Chilcott's Forward-Looking Statements

This press release contains forward-looking statements, including statements concerning our product development efforts. These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The wor
'/>"/>

SOURCE Warner Chilcott Company, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Collaborations planned between British Organization and Indian health care industry
2. More collaborations and strengthening of India’s AIDS control body require
3. Crusade Against Cancer: Collaborations On The Anvil
4. Mayo Clinic and Indian Health Service Form Clinical Practice Collaboration
5. International Collaboration Takes Aim at Rabies
6. A Collaboration to Find New Tools to Fight Leukemia
7. British Medical Association Plans Collaboration With India
8. British Medical Association Plans Collaboration With India
9. LondonMet Keen on Widening Research Collaborations With India
10. Topical Quinolone effective in controlling eardrum perforations
11. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...tingAK,AR,FL,IN,LA,ME,NE,NDandSD ,, ALEXANDRIA...heSenate,svoteonSaturdaytotakeupthehealthcarerefor...wadvertisingcampaigntargetingSenatorsinninestates-...braska,NorthDakota,andSouthDakota. ,, The$2.0mi...dServices(CMS)reportwhichconfirmscutstoMedicareofh...
(Date:11/24/2009)... 2009 Researchers at Ben-Gurion University of the...ncerous skin tumors, including melanomas that aren...sting, the OSPI instrument (Optical Spectro-Polari...hat have never been seen before - including melano...n lesions and were awaiting surgery for their remo...
(Date:11/24/2009)... plastic surgery experts from the American Society...uss the recently proposed cosmetic surgery tax. ,...cus) November 24, 2009 -- Leading plastic surgery ...ons (ASPS), are available to discuss the recently ...the nation’s leading plastic surgery experts...
(Date:11/24/2009)... Software will be Offered Initially to the Academi... (PRWEB) -- Ziosoft®, Inc. a leader in adva...al imaging, is offering its new zioTerm™ bas...h communities. The Windows®-based software ca...ng data from CT, MR, PET, ultrasound and X-ray on ...
(Date:11/24/2009)...ealth System will be offering a free online semina...ein, MD, board certified ophthalmologist and pione...ebinars.com , (Vocus) No...t a live webinar on LASIK Vision Correction &ndash...computer and is free to anyone attending., , ,The ...
Breaking Medicine News(10 mins):Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 2Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 3Health News:New device enables early detection of cancerous skin tumors -- Ben Gurion U. 2Health News:Leading Plastic Surgery Experts Available to Discuss Proposed ,Cosmetic Surgery Tax 2Health News:Ziosoft Releases Free zioTerm Basic 2D/3D Software Application 2Health News:Free LASIK Surgery Webinar 2Health News:Free LASIK Surgery Webinar 3Health News:Free LASIK Surgery Webinar 4
...threshold of launching an oral vaccine for diabete...in injections, promising relief to millions in the...condition. The Andhra Pradesh-based pharmaceut...mical Technology (IICT), Hyderabad. "We have m...
...2-year-old girl was allegedly operated on her leg ...astal district of Jajpur, some 100 km from here, t...as a victim of an unusual case of polio affecting ...esident of Mantira village. He said the doct...
...hildren's Memorial Research Center have, for the f...ene associated with heightened risk //for Alzheime...ihood that brain-injured newborns would develop ce...ebruary issue of the journal Pediatrics, may enabl...
...atest research finding, two thirds of the young po...e to talk to people on this issue. //This research... disorders in London. From a total of six h...reater risk. According to these people, their diso...
...laboratory may pave way to the discovery of a new ...chaefer of Rochester University Medical Center. //...ciated with colon, skin, liver and oesophagal canc... diarrhoea. Cancer cells were used as controls for...
... marks the end of a woman’s reproductive years, us...reasons, some women experience //early menopause. ...ncrease the risk of health problems, including ost...re menopause: Though there is some debate over the...
Other Medicine News:Health News:India Developing Oral Vaccine to Fight Diabetes 2Health News:Newborns' Cerebral Palsy Risk Increased By Alzheimer's Gene 2
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire-FirstCall/--OptimerPh...entatthe21stAnnualPiperJaffrayHealthCareConference...:00p.m.EasternTime. ,, (Logo: http://www.newsco...iveaudiowebcastofthispresentationwillbeaccessibleo...merpharma.com .Replaysofthispresentationwillbeava...
(Date:11/24/2009)..., LYNBROOK,N.Y.,Nov.24/PRNewswire-FirstCall/--BioS...aceuticalcompanydevelopingfirstinclasscollagenase-...dent,TomWegman,willpresentattheupcomingPiperJaffra...,2009,at3:30pmETatTheNewYorkPalaceHotelinNewYork,N...dunder"CalendarofEvents"intheInvestorRelationssect...
(Date:11/23/2009)..., SUNNYVALE,Calif.,Nov.23/PRNewswire-FirstCall/--A...hefieldofradiosurgery,announcedtodaythatitsmanagem...HealthcareConferenceinNewYorkonTuesday,December1,2...ntattheJ.P.MorganSmall/MidCapConferenceinNewYorkon..., Alivewebcastofeachpresentationwillbeavailable...
Breaking Medicine Technology:Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference 2MSU researchers receive 24400 000 in first wave of stimulus funding 8726 1MSU researchers receive 24400 000 in first wave of stimulus funding 8726 2Jefferson receives 241 7 million grant to study stem cells in intervertebral discs of the spine 8723 1Jefferson receives 241 7 million grant to study stem cells in intervertebral discs of the spine 8723 2Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession 47971 1Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession 47971 2Partnership for Prescription Assistance Prepared to Help Idaho Workers Hurt by Recession 47971 3
...nted Today at the American Heart Association Scien...ndo, Florida, BOCA RATON, Fla., Nov. 7 Nabi,Biop...e successful completion,of its Phase 2b trial of N...,s innovative and proprietary investigational vacc...d prevent smoking relapse. The,final 12-month data...
...e 3 trial of Genasense(R) in melanoma opens to glo... treatment of bone disease - Named-patient/com...- Appeal filed to review FDA decision on Genasense...se well-tolerated in new clinical ...v. 7 Genta,Incorporated (Nasdaq: GNTA ) today re...
Other Medicine Technology:Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 7Genta Incorporated Announces Third Quarter 2007 Financial Results 2Genta Incorporated Announces Third Quarter 2007 Financial Results 3Genta Incorporated Announces Third Quarter 2007 Financial Results 4Genta Incorporated Announces Third Quarter 2007 Financial Results 5Genta Incorporated Announces Third Quarter 2007 Financial Results 6Genta Incorporated Announces Third Quarter 2007 Financial Results 7
TPS-TL Spinal Spacer
...esorbable, osteoconductive matrix consisting of hy...ared for use in oral maxillofacial procedures as a...g Pro Osteon 200R has been FDA indicated as a bone...h bone during the healing process. Its interconnec...
O-arm Complete Multidimensional Surgical Imaging
Merlin Patient Care System
Medicine Products: